In addition, it has been reported that targeted lactic acid metabolism can reduce the production of angiogenic factor (VEGF) by downregulating hypoxia-inducible factor 1a (HIF1a), which contributes to the normalization of tumor blood vessels and increases the infiltration of immune cells (40). Here, HIF1A is linked to neoplasm.